Dear Members,
We are glad to announce that in recognition of the central role of pathologists in clinical trials in the era of precision medicine and especially in the field of medical oncology, the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Pathology (ESP) launched a joint ESP-EORTC pathology research fellowship program.
In clinical trials, histological tumor markers assessed by the participating pathologists frequently serve as eligibility criteria for inclusion, stratification factors for target cohort identification or as surrogate endpoint to expedite the trial in neo-adjuvant setting.
In the increasingly common biomarker driven studies most of the time it is the responsibility of the pathology laboratory to ensure all prerequisites for reliable molecular testing and reporting.
In EORTC studies the custodians of annotated human biological samples are pathologists. They ensure the maintenance of quality assured bio-banks for next generation clinical trials and for future research ultimately leading to precision medicine.
The EORTC-ESP fellow is a young pathologist, who will work closely with key opinion leaders in the EORTC-ESP network and will participate in clinical research programs leading toward biomarker discovery and validation.
For more information regarding the EORTC-ESP fellowship, please download the documents below.
You can also visit the dedicated page on our website.Fellowship Proposal
Press